Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7WSS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,970
Award facts
- Contract value 100% obligated
- $58,970.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $58,970.18 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30s. This competitive delivery order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, carries firm fixed-price terms and represents no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its Corporate Office location in that same municipality. This delivery order is issued under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor and critical federal medical procurement vendor, supplying comprehensive pharmaceutical products and medical supplies to military and veteran healthcare systems. The parent IDC vehicle provides the company with the capability to deliver a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other federal healthcare programs globally. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its capability to meet federal procurement standards and fulfill specialized pharmaceutical supply requirements for the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F7WSS?
SPE2DR26F7WSS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F7WSS worth?
The government has obligated $58,970 on SPE2DR26F7WSS.
Is contract SPE2DR26F7WSS an order under another contract?
Yes. SPE2DR26F7WSS is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WSS competed?
The extent of competition for SPE2DR26F7WSS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award